Oxybutynin Chloride
- Product NDC
- 70518-2640
- Requested package NDC
- 70518-2640-3
- 11-digit product format
- 705182640
- Labeler code
- 70518
- Product ID
- 70518-2640_4a7c6cdc-4b20-7a2a-e063-6294a90aaea2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Oxybutynin Chloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA209335
- Marketing category
- ANDA
- Marketing start
- 2020-03-26
- Substance
- OXYBUTYNIN CHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 70518-2640 | 70518-2640-3 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209335-001 | OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-22 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209335-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209335-001 | OXYBUTYNIN CHLORIDE | 5MG | TABLET / ORAL | AB | 2017-12-22 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A209335-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | REMEDYREPACK INC. | 1a08a16a-f16d-4ef1-95bb-6943bcae0737 | 2026-07-28 | Warnings, Adverse reactions | 209335 ANDA209335 70518-2640-3 70518-2640 70518264003 |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Preferred Pharmaceuticals Inc. | 0e002fe8-fa3f-4a7d-84df-0c6e031e6ae4 | 2026-01-15 | Warnings, Adverse reactions | 209335 ANDA209335 |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Northwind Health Company, LLC | 13a79659-a181-6a61-e063-6294a90ae034 | 2025-12-26 | Warnings, Adverse reactions | 209335 ANDA209335 |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 9c8ced4b-94de-4df8-bea3-b42b8846b769 | 2025-03-12 | Warnings, Adverse reactions | 209335 ANDA209335 |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 0c021aad-97a3-4404-a11e-cdd2ec731c6b | 2025-03-07 | Warnings, Adverse reactions | 209335 ANDA209335 |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Bryant Ranch Prepack | f92cf6d0-5f49-40e2-a4f4-8ff377cacbfb | 2025-01-30 | Warnings, Adverse reactions | 209335 ANDA209335 |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | KVK-Tech, Inc. | f99fdfe8-a980-4a72-bc99-aa2ce0bdfd86 | 2024-12-06 | Warnings, Adverse reactions | 209335 ANDA209335 |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 39a2d144-0c10-4aec-9fa4-0adc24b332eb | 2024-06-03 | Warnings, Adverse reactions | 209335 ANDA209335 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Oxybutynin Chloride
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| OXYBUTYNIN CHLORIDE | 5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| L9F3D9RENQ | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1a08a16a-f16d-4ef1-95bb-6943bcae0737 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 3544f362-07fc-93b1-457b-1fba00be087a | Product name | 8 | 20230316 |
| 4daffbf2-44c8-ca46-d284-5db69e1e6ef4 | Product name | 8 | 20210525 |
| 982338c6-c45c-b6b4-1452-14b01fbdf98d | Product name | 2 | 20180801 |
| 054197ba-7ed3-0ddb-321e-dbb51c0fe9b6 | Product name | 2 | 20171212 |
| 3544f362-07fc-93b1-457b-1fba00be087a | Product name | 2 | 20171212 |
| 8b00ae7e-01f2-f83c-632e-edfc23808364 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-2640-0 | Oxybutynin Chloride | 30 in 1 BLISTER PACK | TABLET | 30 | 9 | |
| 70518-2640-1 | Oxybutynin Chloride | 60 in 1 BOTTLE, PLASTIC | TABLET | 60 | 9 | |
| 70518-2640-2 | Oxybutynin Chloride | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | 9 | |
| 70518-2640-3 | Oxybutynin Chloride | 180 in 1 BOTTLE, PLASTIC | TABLET | 180 | 9 | |
| 70518-2640-4 | Oxybutynin Chloride | 30 in 1 BLISTER PACK | TABLET | 30 | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-2640 | OXYBUTYNIN CHLORIDE TABLET [REMEDYREPACK INC.] | 7 | Current NDC, Legacy NDC, 5 package rows | 20250104_1a08a16a-f16d-4ef1-95bb-6943bcae0737.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 863664 | oxyBUTYnin chloride 5 MG Oral Tablet | PSN | 1a08a16a-f16d-4ef1-95bb-6943bcae0737 | 9 |
| 863664 | oxybutynin chloride 5 MG Oral Tablet | SCD | 1a08a16a-f16d-4ef1-95bb-6943bcae0737 | 9 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70518-2640-3 | 70518264003 | 180 TABLET in 1 BOTTLE, PLASTIC (70518-2640-3) | 180 tablet | 2020-06-11 | 0000-00-00 | No | No | Current |